STANLEY R. CHESLER, District Judge.
This matter comes before the Court upon the renewed motion for class certification filed on September 9, 2013 by Plaintiffs Darlery Franco, David Chazen and Camilo Nelson (collectively, "Subscriber Plaintiffs"). Cigna has opposed the motion. The Court denied Subscriber Plaintiffs' first motion for class certification by Order dated January 16, 2013. The Opinion issued by the Court in connection with that Order provides a detailed factual background and defines key terms that likewise apply to this motion, for example "ONET" and "UCR." Because the Court writes for the parties only, it will continue to rely on the same background information without repetition here and will also continue to use the same abbreviated terms as defined in the January 16, 2013 Opinion. (The Opinion relating to the first motion for class certification is reported at 289 F.R.D. 121 (D.N.J. 2013) and will hereinafter be referred to as "Franco I.")
In Franco I, the Court found that Subscriber Plaintiffs had adequately demonstrated that the proposed ERISA class satisfied the Rule 23(a) requirements of commonality and typicality but denied certification in large part because Subscriber Plaintiffs did not carry their burden of demonstrating that common questions of law and fact would predominate over individual issues.
Subscriber Plaintiffs assert that this renewed motion for class certification is not, as Cigna has contended, an untimely motion for reconsideration in disguise. The briefs submitted by Subscriber Plaintiffs, however, unequivocally demonstrate that, in large part, Cigna's characterization of the motion is correct. The briefs contain numerous instances in which Subscriber Plaintiffs refer to the Court's conclusions on the prior class certification motion as "incorrect" and "mistaken." (Mot. at 22; Reply at 8 n.3.) Nevertheless, it is clear to the Court that portions of Subscriber Plaintiffs' motion indeed raise new arguments to address the impediments to class certification discussed in Franco I. The Court will, therefore, entertain this renewed motion for class certification pursuant to Federal Rule of Civil Procedure 23(b)(3), concentrating on Subscriber Plaintiffs' revised approach to demonstrating that the redefined classes — an ERISA Class and a RICO Class — meet the (b)(3) requirements.
This motion corrects some of the problems identified in Franco I. Subscriber Plaintiffs inject greater precision into the definitions of their two proposed classes. They also narrow the UCR language to two basic formulations widely used in Cigna plans during the relevant time period.
Even as pared down, however, the classes do not present common liability issues that will predominate over individual ones. As Cigna points out, even plans that use one of the two broad UCR definitions vary as to the information that Cigna may consider in determining ONET benefits. The record shows multiple combinations of the UCR provisions and additional clauses that influence the determination of an appropriate UCR and ONET benefit. For reasons the Court will discuss, these variations would have a significant impact on a liability analysis. Yet, Subscriber Plaintiffs fail to demonstrate how a classwide trial of the ERISA and RICO claims would cohesively address such combinations and permutations of applicable plan language. Another substantial obstacle to class certification is the lack of any demonstration that injury, an essential component of liability, is capable of classwide proof. The motion makes the erroneous assumption that, if Subscriber Plaintiffs succeed in proving at trial that Ingenix was a flawed database, harm to all members of the redefined ERISA and RICO Classes necessarily follows. In the discussion below, the Court will elaborate on the reasons that Subscriber Plaintiffs' current effort falls short of passing the rigorous analysis that must be applied to ascertain whether the proposed classes actually conform with Rule 23.
The ERISA Class has been redefined in a manner that makes class membership readily ascertainable. According to this motion, the putative class would consist of:
The revised definition includes objective criteria: specific plan language regarding the problematic UCR standard for ONET coverage, the use of Ingenix to determine the allowed amount on an ONET claim, and an allowed amount less than the provider's billed charge. Thus, in line with Subscriber Plaintiffs' theory of the case, the definition captures what the movants allege to be subscribers' rights under their Cigna plans, Cigna's conduct in violation of those rights and injury. In other words, it tailors the class to the ERISA claims at issue in this case: the alleged underpayment of an ONET claim in a manner contrary to plan language because of Cigna's use of Ingenix to determine UCR. The Court notes that the revised ERISA Class definition addresses the issue, raised in Franco I, presented by situations in which the allowed amount is less than the provider's billed charge for reasons unrelated to Ingenix, for example because Ingenix was not used at all or because the subscriber has not yet satisfied his deductible and thus the allowed amount on the claim is zero.
Rule 23(b)(3) requires that questions common to the class predominate such that the class will "prevail or fail in unison" on its claims.
The Court's Rule 23(b)(3) analysis must not consider whether the merits questions will be answered in a plaintiff's favor, but it does "`entail some overlap with the merits of the plaintiff's underlying claim'" to determine whether the class seeking certification has presented common liability questions which are capable of classwide adjudication.
In an ERISA action for recovery of unpaid benefits and/or for breach of fiduciary duty, the critical liability questions depend on plan language. Indeed, the Supreme Court has repeatedly held that adherence to the written terms of the plan in enforcing ERISA rights and obligations is of paramount importance.
The ERISA claims in this case revolve around the plan term which would trigger the use of Ingenix data: UCR. In Franco I, the Court held that Subscriber Plaintiffs cannot meet the predominance standard of Rule 23(b)(3) unless they demonstrate that the same or substantially similar UCR language applies to the entire proposed class. On this renewed motion for class certification, Subscriber Plaintiffs have partially met this requirement. They have presented evidence that during the Class Period, Cigna's plans generally used one of two definitions of UCR. To adopt Subscriber Plaintiffs' nomenclature for distinguishing between the two, the Court will refer to one as the "Reasonable and Customary" or "R&C" definition and the other as the "Maximum Reimbursable Charge" or "MRC1" definition.
The "R&C" definition appears in Named Plaintiff Franco's plan for the years 2001 to 2005. The language in her plan provides as follows:
A charge will be considered Reasonable and Customary if:
(Pl. Ex. 88.)
(Pl. Ex. 33.) The Home Office memo also states that its explanation of Cigna's R&C methodology "applies to approximately 97% of the accounts on Connecticut General's Book of Business." (
The MRC1 definition appears in the Cigna plans of named Plaintiffs Chazen and Nelson. Their plans provide as follows:
Maximum Reimbursable Charge is the
(Pl. Ex. 76, 78.) Subscriber Plaintiffs provide evidence that Cigna began to use this language in or around 2005, apparently as required by the settlement of litigation brought against Cigna by healthcare providers concerning Cigna's managed care practices. They also provide evidence that the MRC1 definition was submitted for approval to the insurance commissioners of jurisdictions nationwide.
Subscriber Plaintiffs try to downplay the differences between R&C and MRC1, describing the switch as a mere "re-naming" of the definition. They point to representations made by Cigna that the UCR language was revised simply to redress providers' concerns that the R&C terminology suggested that amounts billed by providers were not reasonable. They also point to representations made by Cigna that, despite the terminology change, the formula for determining UCR remained the same. While the Court has no reason to doubt these explanations, they do not render the definitions identical. Indeed, a comparison of the provisions quoted above from the plans of the named Plaintiffs demonstrates that the R&C and MRC1 standards used significantly different language. For example, the Franco plan (R&C) caps reimbursement based on the "normal charge made by most providers of such service" whereas the Chazen and Nelson plans (MRC1) cap it based on the "policyholder-selected percentile of all charges made by providers of such service." The terms used by a plan to articulate UCR form a core component of liability in this action, and differences between the R&C standard and the MRC1 standard cannot be overlooked.
Even so, the Court accepts that Subscriber Plaintiffs have sufficiently demonstrated that, during the Class Period, the UCR definitions respectively contained in the Cigna plans of Franco, Chazen and Nelson were widely used in Cigna plans generally. The Court acknowledges Cigna's representation that the R&C and MRC1 definitions which were submitted to state insurance departments were for Cigna's fully-insured plans only and that Cigna-administered self-insured plans were free to choose their own definition of UCR. In Cigna's view, this weakens Subscriber Plaintiffs' attempt to show that a standard UCR definition was in effect. However, the possibility that multiple UCR definitions would overwhelm the action with individual questions is significantly reduced by the incorporation of the UCR terms into the ERISA class definition. It limits membership to those plan subscribers whose plans "promised to pay reasonable and customary amounts defined as the charge of `most providers' in the `same geographic area' or promised a `maximum reimbursable charge' defined as a `percentile of all providers' in the `same geographic area.'" (
Cigna does, however, raise a valid argument in pointing out that even where plans use either the R&C or MRC1 definitions, the plans vary significantly with regard to the methodology that Cigna may, or in some cases must employ to select the appropriate UCR. The variations impact the predominance inquiry in light of the standard by which Cigna's conduct must be reviewed to determine whether it violated ERISA. Any claim of ERISA liability must be proven at trial according to the abuse of discretion standard. The parties have acknowledged that Cigna plans in effect during the Class Period granted Cigna discretionary authority to apply and interpret plan terms. It is well-established ERISA law that where such discretion is granted, the administrator's decision will not be disturbed unless it is "without reason, unsupported by substantial evidence or erroneous as a matter of law."
According to the plans, arriving at the allowed amount is not a purely mechanical operation of determining UCR and comparing it to the provider's charge. As Cigna indicates, many plans, including the plans of the named Plaintiffs, contain a clause which authorizes Cigna to take the nature and severity of the injury or sickness into consideration in determining whether a non-participating provider's charge for the underlying service is reasonable and customary. This criterion, by its nature, calls for investigation into the individual characteristics of the medical issue underlying the claim. Where the plans contain a nature and severity clause, the ERISA claims could not be adjudicated on a classwide basis under any circumstances. The unique and claim-specific assessment Cigna would have to conduct when applying this clause is incompatible with a one-size-fits-all evaluation of the reasonableness of Cigna's decisions according to plan terms. In contrast, some plans do not contain the clause at all. Where the clause is omitted, the analysis of Cigna's benefit determination will necessarily be different than the analysis where the clause is in effect.
Subscriber Plaintiffs suggest that this difference might be addressed by the creation of a subclass to distinguish plans containing the clause (such as Franco's 2001-2004 plans) from those without it (such as Franco's 2005 plan). This suggestion is unavailing. Where the nature and severity of the injury or illness underlying the claim may be considered, the review of a claim decision is inherently sui generis. This individuating factor, together with additional impediments to predominance, renders subclasses an ultimately inadequate way to deal with variations on the R&C and MRC1 provisions across plans.
Alternatively, Subscriber Plaintiffs urge the Court to disregard the nature and severity clause as inconsequential because, according to them, Cigna applied this type of review in the same manner to all appealed claims, whether the governing plan included the clause or not. Subscriber Plaintiffs maintain that even when presented with documentation of increased severity of the illness or injury underlying a claim, Cigna would limit its additional reimbursement to 25% of the initial Ingenix-based UCR. They note that Cigna's own Rule 30(b)(6) witness for claims appeals admitted that Cigna employed this practice of capping additional reimbursement. Thus, they appear to raise two different arguments why the clause does not destroy predominance: one, given Cigna's universal application of the nature and severity adjustments, the clause is essentially included in all plans, whether implicitly or explicitly; and two, despite any appearance that the clause's language would call for an individualized probe into the facts of each claim, Cigna simply adjusted the reimbursement amount by increasing the Ingenix figure, and never more than by 25%. For various reasons, neither argument is availing.
First, the arguments run counter to the settled jurisprudence that ERISA rights and responsibilities are dictated by the plan language, as discussed by the Court above. The view that liability on an ERISA claim to recover unpaid benefits can be established based on evaluating a common practice, without regard to the precise plan language, was recently rejected by Chief Judge Simandle in denying a motion for class certification.
Second, even assuming that Cigna had a practice of capping increasing benefits on appeal based on an adjusted Ingenix figure, it does not follow from this assertion that Cigna uniformly did so each time a subscriber sought additional reimbursement based on the severity of his illness. For example, the record shows that while Franco obtained additional reimbursement on the appeal of her 2003 ONET claim due to the time and complexity of the procedure she underwent, Chazen received no additional reimbursement on his claim because, according to Cigna, he had failed to submit supporting information or documentation with his appeal.
Third, at the risk of sounding repetitive, the Court observes that the argument that uniform application of a severity-based review renders the nature and severity clause irrelevant to a predominance inquiry loses sight of the fact that the ultimate determination on the ERISA claims requires an evaluation of whether Cigna paid ONET benefits in such a way that abused its discretion under the plan or breached its fiduciary duties to subscribers. In any given situation, Cigna's decision to award reimbursement in the amount of the Ingenix UCR plus 25% may have afforded the subscriber the benefit to which the plan entitled her. In other words, after the adjustment, the ultimate allowed amount may have equaled the particular provider's normal charge for the service or amount to a "correct" UCR. Subscriber Plaintiffs propose no way to approach such important liability issues without looking at the individual claim.
Another significant difference among plans concerns the manner in which the plan documents state, if at all, the basis or source of UCR. The plans in the record combine the R&C or MRC1 language with varying statements about how the plan will determine the figure constituting that UCR, or charge of "most" or "all" providers in a geographic area for the type of service on which an ONET claim is based. Some plans provide that the charge is "as determined by CG [Cigna]" (Franco plan), others state that it is "as compiled in a database selected by CG" (Def. Ex. 8), and yet others make the explicit declaration that Cigna uses Ingenix to determine the allowed amount. (Chazen plan, Nelson plan, Def. Exs. 5, 9, 10.) Some plans specify that UCR will be determined according to a percentile of Ingenix charge data. As Subscriber Plaintiffs also recognize, and as this Court has observed in earlier opinions, some plans were subject to a New Jersey state insurance regulation which required that such prevailing fee information be obtained from the Ingenix database. While the Court is not holding that express permission or direction to use Ingenix, be it in the plan documents or in a binding regulation, would necessarily immunize Cigna from potential liability under ERISA, such language must nevertheless be considered as a relevant factor in determining whether or not Cigna's conduct constituted an abuse of discretion or a breach of its fiduciary duty.
Subscriber Plaintiffs acknowledge that some but not all plans specify that Ingenix will be used, but argue that this poses no obstacle to class certification because the Court has already held that Cigna cannot invoke such language to foreclose Subscriber Plaintiffs' Ingenix-based ERISA claims. On the motion to dismiss the Complaint pursuant to Rule 12(b)(6), Cigna had argued that named Plaintiff Chazen had failed to state a claim for ERISA violations because Cigna was simply fulfilling its plan obligation to use Ingenix. Indeed, the Court rejected Cigna's argument. Subscriber Plaintiffs also rely on the Court's reasoning in
In the end, the uniformity Subscriber Plaintiffs believe exists by virtue of two broad UCR definitions is revealed to be illusory. The UCR language is accompanied by significant qualifiers, presenting various combinations of R&C or MRC1 with (or without) the nature and severity clause, a provision granting the plan administrator permission to choose a third party database for UCR, a specific reference to Ingenix as the designated database, and/or direction to calculate UCR at a specific percentile of the database schedules. This creates a fractured landscape for the ERISA claims of the putative class, and under the stringent requirements of Rule 23(b)(3), an inappropriate setting for class action litigation.
In addition to the obstacles presented by varying plan language, establishing that issues common to the ERISA Class predominate over individual issues is hindered by a lack of evidence that injury to all class members may be proven in one stroke. Subscriber Plaintiffs have approached the predominance analysis as if a successful demonstration that Ingenix was flawed will be game, set and match for the ERISA claims of the entire class. Not so. Establishing that Ingenix is flawed is a necessary but insufficient component of proving liability in this case. The theory of Subscriber Plaintiffs' ERISA claims requires that they demonstrate, at a minimum, that Cigna's use of Ingenix constituted an abuse of its discretion, a multifactorial inquiry that must take into consideration the particular plan's language and the available alternative methods for determining UCR. Then, to establish that a subscriber warrants relief under ERISA § 502(a), they must demonstrate that Cigna's conduct in violation of the plan injured the subscriber. In other words, to prove liability, Subscriber Plaintiffs will have to demonstrate that using Ingenix to determine the allowed amount on an ONET claim was arbitrary and capricious and that it resulted in an incorrect award of benefits under the plan.
Recall that under either the R&C or the MRC1 formulation, the allowed amount on an ONET claim is the lesser of the provider's normal charge for the service or the UCR for the service. In the Complaint, Subscriber Plaintiffs had alleged that a multitude of flaws in the Ingenix database resulted in a pool of charge data that was artificially depressed. Instead of containing accurate figures reflecting amounts that providers in any given geographic area really charge patients, Subscriber Plaintiffs contended, the database was manipulated so that, by design, the UCR schedules it generated were skewed downward. According to the allegations of the Complaint, the injury consisted of an underpayment of benefits, or to put it slightly differently, reimbursement for ONET services that was inadequate because Ingenix yielded UCRs that were lower than the true prevailing fees for services. As Cigna has forcefully argued, "Plaintiffs have long since abandoned their theory that Ingenix suffers from a downward bias." (Opp'n at 48.) Subscriber Plaintiffs do not contest this assertion, and the Court therefore deems their abandonment of the downward bias theory conceded.
According to the Complaint, the common contention holding the putative class together as a cohesive group was that the downward bias of Ingenix data had caused all those Cigna subscribers who were subjected to Ingenix-based ONET reimbursements to receive a lesser benefit amount than they were entitled to under the plan. As pled, the named Plaintiffs and the Cigna subscribers they purported to represent had been injured because Ingenix supplied fee schedules that were systematically too low to constitute a "true UCR." The pleading stage of this action has long passed, and Rule 23 demands more than mere allegations. At the class certification stage, the Court must assess the available evidence — not, of course, to consider the strength of Subscriber Plaintiffs' claims but to determine whether those claims "can be productively litigated at once."
Another hurdle to class certification continues to be the failure by Subscriber Plaintiffs to demonstrate that damages can be tried without relying on individualized proof as to each class member and each ONET claim allegedly determined in violation of ERISA. The ERISA Class cannot be certified under Rule 23(b)(3) unless Subscriber Plaintiffs establish, by a preponderance of the evidence, that the injury suffered by class members is measurable on a classwide basis using common proof.
Notwithstanding the holding of
Subscriber Plaintiffs take the position that the Court's analysis reflects a mistaken interpretation of the ONET provision. They underscore that, according to Cigna plans, "[t]he term `charges' means the actual billed charges except when the provider has contracted directed or indirectly with CG for a different amount." (Mot. at 24, quoting from the plans of each of the named Plaintiffs). This assertion is correct. However, the plan language the Court is called upon to consider provides that the ONET allowed amount cannot exceed the healthcare provider's "normal charge." Nothing in the plan documents suggests that the word "normal" should be read out of the ONET provision.
In short, there continues to be a disconnect between plan language and the method proposed by Subscriber Plaintiffs to determine the class members' damages in a cohesive manner. The method cannot, therefore, survive the rigorous analysis that
Recent class action jurisprudence has been clear: In
The stringent nature of the predominance requirement reflects the paramount Rule 23 concern with the manageability of a class action trial.
The Court wishes to be abundantly clear about its conclusion. It is not expressing any opinion as to the merits of the ERISA claims, and it is certainly not concluding that putative class members have sustained no compensable harm. However, the analysis that must be performed to determine if a claim for ONET benefits was properly decided according to plan language cannot be performed en masse. Indeed, even among the three named Plaintiffs, the governing plan language and the factual circumstances of the underlying ONET claims vary widely.
The renewed attempt to certify a RICO Class requires very little discussion. The mail and wire fraud on which the RICO claim in this case is predicated turn on the alleged underpayment of benefits under the applicable Cigna plan; that is, Cigna's alleged failure to perform as promised in the plan "would be evidenced by . . . [Cigna's] denial of benefits due under the insurance arrangement."
Subscriber Plaintiffs request, as an alternative to certification of the ERISA and RICO claims, that the Court certify specific core liability issues respecting those claims under Rule 23(c)(4). They identify three ERISA issues they believe can be tried in common: (1) whether the Ingenix database was so flawed as to be incapable of supporting a reliable reimbursement methodology; (2) whether Cigna's reliance on Ingenix data was a breach of its fiduciary duty for purposes of the ERISA § 502(a)(3) claim; and (3) whether Cigna's denial of benefits under ERISA § 502(a)(1)(B) was an interpretation that was not reasonably consistent with unambiguous plan language. On the RICO claims, Subscriber Plaintiffs assert that the issues of whether Cigna and Ingenix formed an enterprise and whether Cigna engaged in a pattern of mail and wire fraud in the conduct of that enterprise may be certified under Rule 23(c)(4).
Rule 23(c)(4) states that "[w]hen appropriate, an action may be brought or maintained as a class action with respect to particular issues." Issue certification is a matter left to the Court's discretion, but the decision to certify a particular issue, like any other certification decision under Rule 23, "must be supported by rigorous analysis."
There is no doubt that the issue of whether the Ingenix database itself was flawed is a complex issue, and moreover, one that impacts the ERISA claims of the entire class. Certification of this issue, however, would not materially advance the liability issues at the core of Plaintiff's § 502(a)(1)(B) and § 502(a)(3) claims. As the Court discussed at length above, even assuming Subscriber Plaintiffs succeed in establishing that Ingenix was defective, resolving the question of Cigna's liability to class members entails individualized, plan-specific and claimspecific inquiries to determine whether, by reference to various other language affecting the ONET benefit Cigna was obligated to pay, its determination breached fiduciary duties (as defined by the plan) or constituted an arbitrary and capricious application of plan terms. Class adjudication of the validity of Ingenix would not only leave critical remaining liability issues unanswered but also fail to achieve any efficiency in the resolution of class members' claims. A court would be required to conduct mini-trials to establish the elements of the ERISA claims for unpaid benefits and breach of fiduciary duty in light of the nuances of each plan's instructions to the administrator.
The other ERISA issues for which Subscriber Plaintiffs seek certification are even less suited to common, classwide resolution. It is not only the issue of quantifying the appropriate damage award to each class member which presents the need to conduct an individualized analysis of plan language and underlying facts. Rather, the very occurrence of an ERISA violation will vary from class member to class member, and for each class member, from one ONET claim to another. Moreover, like the damages calculation, determining whether Cigna has underpaid an ONET claim and/or breached its fiduciary duty to discharge plan obligations requires consideration of the plan language, entitling plan subscribers to an ONET allowed amount that does not exceed the provider's normal charge. Where "liability is inseverable from other issues that would be left for follow-up proceedings," the Court may decline to certify a liability-only issue class.
This Court agrees with the conclusion reached by Judge Debevoise in
Certifying only certain RICO issues is similarly inefficient. Even if the question of whether Cigna and Ingenix formed an enterprise within the meaning of the statute could be resolved as to all members of the putative RICO Class, substantial liability questions would remain unanswered without a member by member and claim by claim analysis of the alleged failure to perform as promised by the plan.
The alternative request for class treatment of particular issues, pursuant to Rule 23(c)(4), will accordingly be denied.
This motion fails to satisfy the requirements for certification of a Rule 23(b)(3) class as to either the proposed ERISA Class or the proposed RICO Class. For the reasons discussed, Subscriber Plaintiffs have not demonstrated that they could litigate their claims through evidence that is common to the class. Moreover, issue certification, as permitted by Rule 23(c)(4), would not advance the resolution of the claims, and thus this action does not warrant exercise of the Court's discretion to certify certain issues.
An Order denying Subscriber Plaintiffs' renewed motion for class certification in its entirety will be filed.
Once again, as in the previous attempt at class certification, Subscriber Plaintiffs take the position that the correct standard is review de novo. Their sole argument is that the Court's prior decision is wrong. As noted earlier in this Opinion, the Court is not treating this as a motion for reconsideration. If it were, however, the Court's finding as to the applicability of the abuse of discretion standard to Plaintiff's ERISA § 502(a) claim would not warrant reconsideration, both for the motion's untimeliness — filed nine months after the Franco I decision — and for its failure to meet the standard for reconsideration. L.Civ.R. 7.1(i) (providing that a party may move for reconsideration "within 14 days after the entry of the order or judgment on the original motion" by the court);
The Third Circuit will surely give Subscriber Plaintiffs' arguments a full and careful review, as this Court has already done, and render its own decision about whether this Court misinterpreted the law.
Dr. Siskin, whose report identifies the inadequacies of the Ingenix database, was asked at his deposition: "And so it's fair to say that you cannot give the opinion that the Ingenix database systematically for every class member resulted in the payment of a UCR amount that was lower than a true UCR?" He answered: "I think I've said 14 times, since I don't know the true UCR, I can't make that statement." (1/30/2012 Deni Decl. Ex. 33 at 448:6-11, 448:15-17.)
Dr. Foreman, when deposed concerning an opinion on which Plaintiffs ultimately did not rely, similarly admitted that the Ingenix UCR data did not necessarily result in an underpayment of ONET claims, as compared to the amounts subscribers would have received based on the "accurate" billed charge percentiles he created. The transcript, in relevant part, reads as follows:
(
(Mot. at 3.)